Ameliorative Impact of Liraglutide on Chronic Intermittent Hypoxia-Induced Atrial Remodeling

Atrial fibrillation (AF) is the most frequent form of clinical cardiac arrhythmias. Previous evidence proved that atrial anatomical remodeling (AAR) and atrial electrical remodeling (AER) are crucial for the progression and maintenance of AF. This study is aimed at investigating the impact of the gl...

Full description

Saved in:
Bibliographic Details
Main Authors: Jun Wang, Yongzheng Liu, Changhui Ma, Yue Zhang, Meng Yuan, Guangping Li
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2022/8181474
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832558339396993024
author Jun Wang
Yongzheng Liu
Changhui Ma
Yue Zhang
Meng Yuan
Guangping Li
author_facet Jun Wang
Yongzheng Liu
Changhui Ma
Yue Zhang
Meng Yuan
Guangping Li
author_sort Jun Wang
collection DOAJ
description Atrial fibrillation (AF) is the most frequent form of clinical cardiac arrhythmias. Previous evidence proved that atrial anatomical remodeling (AAR) and atrial electrical remodeling (AER) are crucial for the progression and maintenance of AF. This study is aimed at investigating the impact of the glucagon-like peptide-1 (GLP-1) receptor agonist, Liraglutide (Lir), on atrial remodeling (AR) mouse model induced by chronic intermittent hypoxia (CIH). C57BL/6 mice were categorized randomly into the control, Lir, CIH, and CIH+Lir groups. CIH was performed in CIH and CIH+Lir groups for 12 weeks. Lir (0.3 mg/kg/day, s.c) was administered to the Lir and CIH+Lir groups for four weeks, beginning from the ninth week of CIH. Meanwhile, echocardiography and right atrial endocardial electrophysiology via jugular vein, as well as induction rate and duration of AF, were evaluated. Masson and Sirius red staining assays were utilized to assess the extent of fibrosis in the atrial tissue of the mice. Immunohistochemical staining, RT-qPCR, and Western blotting were performed to evaluate the marker levels of AAR and AER and the expression of genes and proteins of the miR-21/PTEN/PI3K/AKT signaling pathway, respectively. ELISA was also performed to evaluate the changes of serum inflammatory factor levels. The CIH group exhibited significant AR, increased atrial fibrosis, and a higher incidence rate of AF compared to the control group. Lir could significantly downregulate the protein expression level in the PI3K/p-AKT pathway and upregulated that of phosphatase and tensin homolog deleted on chromosome ten (PTEN). Moreover, Lir downregulated the expression of miR-21. However, the protein expressions of CACNA1C and KCNA5 in atrial tissue were not changed significantly. In addition, Lir significantly attenuated the levels of markers of inflammation (TNF-α and IL-6) in the serum. In the mouse model of CIH, Lir treatment could ameliorate AR by the miR-21/PTEN/PI3K/AKT signaling pathway and modulation of inflammatory responses.
format Article
id doaj-art-b2f16ff61a3f41c582452f4f77f33d27
institution Kabale University
issn 2314-7156
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-b2f16ff61a3f41c582452f4f77f33d272025-02-03T01:32:34ZengWileyJournal of Immunology Research2314-71562022-01-01202210.1155/2022/8181474Ameliorative Impact of Liraglutide on Chronic Intermittent Hypoxia-Induced Atrial RemodelingJun Wang0Yongzheng Liu1Changhui Ma2Yue Zhang3Meng Yuan4Guangping Li5Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular DiseaseTianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular DiseaseTianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular DiseaseTianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular DiseaseTianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular DiseaseTianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular DiseaseAtrial fibrillation (AF) is the most frequent form of clinical cardiac arrhythmias. Previous evidence proved that atrial anatomical remodeling (AAR) and atrial electrical remodeling (AER) are crucial for the progression and maintenance of AF. This study is aimed at investigating the impact of the glucagon-like peptide-1 (GLP-1) receptor agonist, Liraglutide (Lir), on atrial remodeling (AR) mouse model induced by chronic intermittent hypoxia (CIH). C57BL/6 mice were categorized randomly into the control, Lir, CIH, and CIH+Lir groups. CIH was performed in CIH and CIH+Lir groups for 12 weeks. Lir (0.3 mg/kg/day, s.c) was administered to the Lir and CIH+Lir groups for four weeks, beginning from the ninth week of CIH. Meanwhile, echocardiography and right atrial endocardial electrophysiology via jugular vein, as well as induction rate and duration of AF, were evaluated. Masson and Sirius red staining assays were utilized to assess the extent of fibrosis in the atrial tissue of the mice. Immunohistochemical staining, RT-qPCR, and Western blotting were performed to evaluate the marker levels of AAR and AER and the expression of genes and proteins of the miR-21/PTEN/PI3K/AKT signaling pathway, respectively. ELISA was also performed to evaluate the changes of serum inflammatory factor levels. The CIH group exhibited significant AR, increased atrial fibrosis, and a higher incidence rate of AF compared to the control group. Lir could significantly downregulate the protein expression level in the PI3K/p-AKT pathway and upregulated that of phosphatase and tensin homolog deleted on chromosome ten (PTEN). Moreover, Lir downregulated the expression of miR-21. However, the protein expressions of CACNA1C and KCNA5 in atrial tissue were not changed significantly. In addition, Lir significantly attenuated the levels of markers of inflammation (TNF-α and IL-6) in the serum. In the mouse model of CIH, Lir treatment could ameliorate AR by the miR-21/PTEN/PI3K/AKT signaling pathway and modulation of inflammatory responses.http://dx.doi.org/10.1155/2022/8181474
spellingShingle Jun Wang
Yongzheng Liu
Changhui Ma
Yue Zhang
Meng Yuan
Guangping Li
Ameliorative Impact of Liraglutide on Chronic Intermittent Hypoxia-Induced Atrial Remodeling
Journal of Immunology Research
title Ameliorative Impact of Liraglutide on Chronic Intermittent Hypoxia-Induced Atrial Remodeling
title_full Ameliorative Impact of Liraglutide on Chronic Intermittent Hypoxia-Induced Atrial Remodeling
title_fullStr Ameliorative Impact of Liraglutide on Chronic Intermittent Hypoxia-Induced Atrial Remodeling
title_full_unstemmed Ameliorative Impact of Liraglutide on Chronic Intermittent Hypoxia-Induced Atrial Remodeling
title_short Ameliorative Impact of Liraglutide on Chronic Intermittent Hypoxia-Induced Atrial Remodeling
title_sort ameliorative impact of liraglutide on chronic intermittent hypoxia induced atrial remodeling
url http://dx.doi.org/10.1155/2022/8181474
work_keys_str_mv AT junwang ameliorativeimpactofliraglutideonchronicintermittenthypoxiainducedatrialremodeling
AT yongzhengliu ameliorativeimpactofliraglutideonchronicintermittenthypoxiainducedatrialremodeling
AT changhuima ameliorativeimpactofliraglutideonchronicintermittenthypoxiainducedatrialremodeling
AT yuezhang ameliorativeimpactofliraglutideonchronicintermittenthypoxiainducedatrialremodeling
AT mengyuan ameliorativeimpactofliraglutideonchronicintermittenthypoxiainducedatrialremodeling
AT guangpingli ameliorativeimpactofliraglutideonchronicintermittenthypoxiainducedatrialremodeling